Determination of trimepranol, chlorthalidone, DH-ergocristine and amiloride simultaneously
Peterková, M.; Kakác, B.; Matousová, O.
Ceskoslovenska Farmacie 29(7): 241-243
1980
ISSN/ISBN: 0009-0530 PMID: 6110484 Document Number: 157565
Document emailed within 1 workday
Related Documents
de Pasquale, C.; Currò, F.; Amadeo, A. 1978: Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone Minerva Medica 69(31): 2115-2123Luis, M.L.; García, J.M.; Jiménez, F.; Jiménez, A.I.; Arias, J.J. 1999: Simultaneous determination of chlorthalidone and spironolactone with univariate and multivariate calibration: wavelength range selection Journal - Association of Official Analytical Chemists 82(5): 1054-1063
Pierce, G.N.; Cole, W.C.; Liu, K.; Massaeli, H.; Maddaford, T.G.; Chen, Y.J.; McPherson, C.D.; Jain, S.; Sontag, D. 1993: Modulation of cardiac performance by amiloride and several selected derivatives of amiloride Journal of Pharmacology and Experimental Therapeutics 265(3): 1280-1291
Howard, M.J.; Hughes, R.J.; Motulsky, H.J.; Mullen, M.D.; Insel, P.A. 1987: Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors Molecular Pharmacology 32(1): 53-58
Sulková, A.; Kolláriková, E.; L' Krasnec 1980: Interaction of trimepranol and uric acid Ceskoslovenska Farmacie 29(8-9): 294-295
Málek, I.; Kolc, J.; Mrhová, O.; Urbanová, D. 1981: The effect of trimepranol in the ischaemic focus in the dog Cor et Vasa 23(4): 299-309
Jebavý, P.; Málek, I.; Beránek, I. 1982: Congestive cardiomyopathy--trimepranol induced haemodynamic changes Casopis Lekaru Ceskych 121(2): 45-51
Oral, I.; Vizinová, H. 1990: Echocardiographic control of treatment of mild hypertension with trimepranol Vnitrni Lekarstvi 36(7): 633-638
Charvát, J.; Hlavácek, K. 1992: Hemodynamic effects of nitroglycerin and trimepranol in acute myocardial infarct Vnitrni Lekarstvi 38(7): 658-663
Zamrazil, V.; Felt, V.; Nĕmec, J.; Vána, S. 1972: Effects of trimepranol and propranolol on glucide and free fatty acid metabolism in thyrotoxicosis Casopis Lekaru Ceskych 111(14): 312-316
Tikal, K.; Hvizdosová, J.; Pavlovicová, E. 1980: Spontaneous motor activity in rats given repeatedly beta-sympatholytics, propranolol and trimepranol Activitas Nervosa Superior 22(1): 71-72
Felt, V.; Vána, S.; Zamrazil, V. 1971: Effect of adrenergic blockade by trimepranol and propranolol on protein iodine and the severity of thyrotoxicosis Casopis Lekaru Ceskych 110(25): 595-597
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Tilser, I.; Chmelar, V.; Krupicková, H. 1980: The toxic effects and pharmacokinetics of lanatoside C in animals with experimental radiation sickness or trimepranol premedication Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Suppl 23(4): 497-511
Sumiye, L.; Vivian, A.S.; Frisof, K.B.; Podany, E.C. 1981: Potassium loss associated with hydrochlorothiazide versus chlorthalidone Clinical Therapeutics 4(4): 308-320
Benedetti, A.; Carassai, A.; Nosdeo, A. 1987: Hyperglycemic hyperosmolar coma without ketoacidosis during treatment with chlorthalidone La Clinica Terapeutica 120(2): 155-159
Kreeft, J.H.; Larochelle, P.; Ogilvie, R.I. 1983: Comparison of chlorthalidone and spironolactone in low--renin essential hypertension Canadian Medical Association Journal 128(1): 31-34
Koval, P.G.; McDiarmid, T. 2000: How effective is doxazosin compared with chlorthalidone in the treatment of hypertension? Journal of Family Practice 49(7): 597-598
Fagerberg, S.E.; Göransson, K. 1974: A comparative study of spironolactone and chlorthalidone in treatment of hypertension Lakartidningen 71(3): 175-177
Kjaerulff, J.; Lyngsoe, J. 1973: The antihypertensive effects of bendroflumethiazide, hydroflumethiazide, trichlormethiazide, chlorthalidone and furosemide Ugeskrift for Laeger 135(33): 1744-1746